NDRA
ENDRA Life Sciences Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$4.75
+0.21%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$4.99
From 52W high−29.10%
Volume9508.00
Market cap$7.12M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$4.99
From 52W high
−29.10%
Volume
9508.00
Market cap
$7.12M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.8x
P/E (TTM)
—
RSI (14)
39.5
MomentumView details →
1D Return
+0.21%
YTD Return
+6.62%
SummaryUpdated Jun 1, 2026
ENDRA Life Sciences Inc. (NASDAQ:NDRA) is a medical technology company founded in 2007 and based in Ann Arbor, Michigan. The company went public in June 2017 and focuses on developing advanced ultrasound imaging technology for medical diagnostics. ENDRA specializes in thermo-acoustic enhanced ultrasound (TAEUS) technology, which represents a novel approach to medical imaging that combines traditional ultrasound with photoacoustic principles to provide enhanced diagnostic capabilities for physicians.
Similar companies
Latest newsMore news →
ENDRA Life Sciences amended its Agreement and Plan of Merger with ASP Isotopes, Noble Africa and Renergen, revising the minimum cash closing condition to $3,800,002.59 and increasing Renergen's borrowing capacity under the ASPI Term Loan Facility from $80 million to up to $200 million.18d agoENDRA Life Sciences amended a common stock purchase warrant held by LHE LNG Holdings to remove the 4.99% beneficial ownership limitation, with exercise conditional on stockholder approval.18d agoASP Isotopes plans to create a publicly listed helium and LNG platform through Noble Africa.90d ago